In metabolic disorders like as atherosclerosis and obesity, LDLRAD4_AS1 influences lipid metabolism pathways through the modulation of low-density lipoprotein receptor-associated protein 4 (LDLRAD4) expression (23). Here, LDLRAD4 is linked to metabolic disease.